CLINICAL_TRIALS
trial_result
· 2011-06-14
Clinical Trial Update: Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 trial evaluating safety, tolerability, and activity of HE3286 in patients with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Harbor Therapeutics | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED